The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2019
DOI: 10.1007/s00284-019-01653-4
|View full text |Cite
|
Sign up to set email alerts
|

Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases

Abstract: Burkholderia contaminans is a member of the Burkholderia cepacia complex (Bcc), a pathogen with increasing prevalence among cystic fibrosis (CF) patients and the cause of numerous outbreaks due to the use of contaminated commercial products. The antibiotic resistance determinants, particularly β-lactamases, have been poorly studied in this species. In this work, we explored the whole genome sequence (WGS) of a B. contaminans isolate (FFH 2055) and detected four putative β-lactamase-encoding genes. In general, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 52 publications
(50 reference statements)
0
1
0
Order By: Relevance
“…However, the Burkholderia genus also comprises certain pathogenic species that threaten plant, animal, and human health [ 16 ]. Burkholderia contaminans is a member of the Burkholderia cepacia complex (Bcc) [ 17 ] which includes several closely related Burkholderia species. These opportunistic pathogens frequently colonize the lungs of cystic fibrosis (CF) and immune-compromised patients [ 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, the Burkholderia genus also comprises certain pathogenic species that threaten plant, animal, and human health [ 16 ]. Burkholderia contaminans is a member of the Burkholderia cepacia complex (Bcc) [ 17 ] which includes several closely related Burkholderia species. These opportunistic pathogens frequently colonize the lungs of cystic fibrosis (CF) and immune-compromised patients [ 18 ].…”
Section: Introductionmentioning
confidence: 99%